Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
Profitability Metrics
Gross Margin
83.30%
Operating Margin
24.56%
Net Margin
29.13%
Efficiency Metrics
Revenue per Expense Ratio
1.33
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
37.21%
Income Tax Rate
5.91%
EPS
0.3000000000
Balance Sheet Analysis
Current Ratio
6.45
Cash Ratio
5.54
Working Capital
$24.76M
Debt to Equity
0.01
Debt to Assets
0.93%
Equity Ratio
90.81%
Cash Flow Analysis
Operating Cash Flow Ratio
34.05%
Free Cash Flow Ratio
33.69%
CapEx to Revenue
0.36%
Dividends Paid
$1.72M
Stock Buybacks
$3.88M
Total Shareholder Returns
$5.61M
Cash Position Change
4.85%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Increased dividend payments by 23.04%
Detailed Growth Metrics
Core Performance
Revenue
7.09%
Net Income
6.58%
EPS
11.11%
Operating Income
-1.30%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
12.52%
Operating Cash Flow
-21.40%
Free Cash Flow
-13.39%
Balance Sheet Health
Assets
2.00%
Debt
-35.62%
Book Value per Share
3.26%
Inventory
-100.00%
Shareholder Returns
Dividends per Share
23.04%
Shares Outstanding
-1.11%
Long Term Trends
3Y Revenue/Share
4.32%
5Y Revenue/Share
5.36%
3Y Dividend/Share
214.54%
5Y Dividend/Share
326.85%